Company Description

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.

Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata.

The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025.

ImageneBio, Inc. is headquartered in San Diego, California.

ImageneBio, Inc.

Country	United States
Founded	2019
Industry	Biotechnology
Sector	Healthcare

Contact Details

Address: 12526 High Bluff Drive, Suite 345 San Diego, California 92130 United States
Phone	617-901-7098
Website	inmagenebio.com

Stock Details

Ticker Symbol	IMA
Exchange	NASDAQ
Reporting Currency	USD
CIK Code	0001835579